基于影像组学的模型预测肌层浸润性膀胱癌新辅助化疗病理完全缓解
本研究利用基线CT图像开发并验证基于影像组学的模型,用于预测肌层浸润性膀胱癌患者对新辅助化疗的病理完全缓解。训练集87例,独立验证集48例(来自外部机构CT)。模型结合影像组学标签、肿瘤形状、大小和临床分期,训练集AUC 0.85(95%CI 0.78-0.93),验证集AUC 0.75(95%CI 0.60-0.86),阳性似然比1.91高于影像和组织学预测因子(1.33-1.63)。
要点
- 基线CT影像组学模型可预测MIBC新辅助化疗后病理完全缓解。
- 模型在训练集AUC 0.85,外部验证集AUC 0.75,具有较好泛化性。
- 模型阳性似然比1.91,高于影像和组织学预测因子(1.33-1.63)。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To develop and validate a radiomics-based model for predicting response to neoadjuvant chemotherapy (NAC) using baseline computed tomography (CT) images in patients with muscle-invasive bladder cancer (MIBC).
MATERIALS AND METHODS: A radiomics signature for predicting pathological complete response (pCR) was developed using radiomics features selected by a random forest classifier on baseline CT images, and imaging predictors were identified in the training set (87 patients). By incorporating imaging predictors and radiomics signature, an imaging-based model was constructed using multivariate logistic regression analysis and validated in an independent validation set consisting of 48 patients with CT from outside institutions. The performance and clinical usefulness of the imaging-based model for predicting pCR were evaluated using area under the receiver operating characteristic curve (AUC) and decision curve analysis. Using a cut-off determined in the training set, the positive likelihood ratios of the imaging-based model were calculated and compared with imaging and histological predictors.
RESULTS: The radiomics signature was developed based on six stable radiomics features. An imaging-based model incorporating radiomics signature, tumour shape, tumour size, and clinical stage showed good performance for predicting pCR in both the training (AUC, 0.85; 95% confidence interval [CI], 0.78-0.93) and validation (AUC, 0.75; 95% CI, 0.60-0.86) sets, providing a larger net benefit in decision curve analysis. The imaging-based model showed a higher positive likelihood ratio (1.91) for pCR than imaging and histological predictors (1.33-1.63).
CONCLUSIONS: The radiomics-based model using baseline CT images may predict the response of patients with MIBC to NAC.
引用
- Choi SJ, Park KJ, Heo C, et al. Radiomics-based model for predicting pathological complete response to neoadjuvant chemotherapy in muscle-invasive bladder cancer. Clin Radiol. 2021. PMID: 33762138. doi:10.1016/j.crad.2021.03.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。